Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: Tablets and pellets

Pakistan Journal of Pharmaceutical Sciences

Volumn 21, Issue 2, 2008, Pages 131-138

  Tulain, Umeruqia ^a   Nisar Ur Rahman, ^a,b  

^a THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bioavailability; In vitro; In vivo correlation; Sustained release; Theophylline

Indexed keywords

GUAIFYLLINE; QUIBRON SR; RESPRO SR; THEOPHYLLINE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; TABLET FORMULATION; BIOAVAILABILITY; BLOOD; DRUG IMPLANT; KINETICS; SOLUBILITY; TABLET;

ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; DRUG IMPLANTS; HUMANS; KINETICS; MALE; SOLUBILITY; TABLETS; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 44449093677     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Al-Ghazawi M and Majali AS (2000). Comparative bioavailability of two test brands of theophylline; tablets and reference Quibron-T/SR under fasting and limited food conditions. Medical Journal of Islamic Academy of Sciences, 13(3): 109-114.
2. Bechgaard H (1982). Critical factors influencing gastrointestinal absorption - what is the role of pellets? Acta. Pharm. Technol., 28(2): 149-157.
3. Biagini L., Zamora P, Chavez H and Saavedra I (1990). The bioavailability of four sustained-release theophylline preparations from the Chilean market. Rev. Med. Chil., 118(11): 1241-1246.
4. nd eds., New York: Marcel Dekker Inc., pp.145-195.
5. James TD and Marvin CM (2002). Bioavailability of drugs and bioequivalence, in Encyclopedia of Pharmaceutical Technology, Marcel Dekker Inc., p.125.
6. Kanthawatana S, Ahrens RC, McCubbin M, Bronsky E, Blake K and Hendeles L (1994). Bioequivalence of a generic slow-release theophylline tablet in children. J. Pediatr., 125: 987-991. (Pubitemid 24379138)
7. Keinke O (1989). Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage. Arzneimittelforschung, 39(11): 1460-1464.
8. Kiivet RA, Teder P, Pruunsild T and Svensson JO (1992). Bioavailability of two Soviet sustained-release theophylline formulations in comparison with TheoDur. Pharmacol. Toxicol., 71(5): 388-390.
9. Peter JB (2003). Pulmonary perspective theophylline new perspectives for an old drug. American Journal of Respiratory and Critical Care Medicine. 167: 813-818.
10. Peh KK and Yuen KH (1996). In vivo performance of multiparticulate matrix, controlled-release theophylline preparation. Drug Development and Industrial Pharmacy, 22(4): 349-355. (Pubitemid 26128953)
11. th eds., McGraw Hill, Singapore, pp.3, 453-462.
12. Shishoo CJ and Savale SS (1999). Sensitive HPLC method for bioavailability and bioequivalence studies of theophylline sr formulations. Indian J. Pharm. Sci., 61(6): 350-357.
13. United State Pharmacopeia 24/National Formulary 19 (2000).
14. st ed.), Illinois: Drug Intelligence Publication, pp.285-305.
15. Wagner JG and Nelson E (1964). Kinetic analysis of blood levels and urinary excretion in the absorption phase after single doses of drugs. J. Pharm. Sci. 53: 1392-1403.
16. Weiner DL (1981). Design and analysis of bioavailability studies. In: Statistics in the Pharmaceutical Industry (Buncher, C.R., Tsay, J.Y. ed.), Marcel Dekker Inc., New York, pp.205-229.
17. West RJ, Boehm G, Dwyer M, Williams DB, Sansom LN and Penna AC (1990). Bioavailability of a new sustained-release theophylline capsule in fasted and non-fasted healthy subjects: single and multiple dosing studies. Biopharm. Drug Dispos., 11(2): 165-177. (Pubitemid 20164635)
18. Yuen KH, Desmukh AA and Newton JM (1993). In vivo/in vitro correlation of experimental sustainedrelease theophylline formulations. Pharm. Res., 10(4): 588-592.
19. Yuen KH, Peh KK, Quah YL and Chan K Lam (1997). A novel simultaneous HPLC assay for serum paracetamol and sulfapyridine as markers of gastric emptying and orocecal transit. Drug Development and Industrial Pharmacy, 23(2): 225-228.